China Grand Pharmaceutical and Healthcare Holdings Ltd.

China Grand Pharmaceutical and Healthcare Holdings Limited (512.HK) is a globally integrated healthcare enterprise principally engaged in research and development, manufacture and sales of pharmaceutical preparations, high-end medical devices, specialized pharmaceutical raw materials and nutrition products. The Company’s core products cover the three business areas represented by Ear, Nose & Throat and Eye (the “ENT”), cerebo-cardiovascular emergency medicine, and high-end medical devices, biotechnology and specialized raw materials. The Company is constantly transforming itself towards the direction of internationalization and R & D innovation, rationalizing its product line through organic growth and international merger and acquisition, and utilizing its abundant commercialization capability and strong sales network, accelerate the landing of high-quality projects and drugs in the world’s cutting-edge core treatment field in China and other countries..